Ching Jaw - Mar 6, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
SVP Finance & CFO
Signature
/s/ John Faurescu, attorney-in-fact for Mr. Jaw
Stock symbol
CYTK
Transactions as of
Mar 6, 2023
Transactions value $
$0
Form type
4
Date filed
3/7/2023, 03:15 PM
Previous filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Award $0 +30K +52.31% $0.00 87.3K Mar 6, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (Right to Buy) Award $0 +2.56K $0.00 2.56K Mar 6, 2023 Common Stock 2.56K $39.13 Direct F2
transaction CYTK Non-Qualified Stock Option (Right to Buy) Award $0 +47.4K $0.00 47.4K Mar 6, 2023 Common Stock 47.4K $39.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.
F2 This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.